Skip to main content
Figure 3 | BMC Medicine

Figure 3

From: Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study

Figure 3

Evolution of mean with standard deviation of biological markers in diabetic patients under treatment. Evolution of (a) random blood glucose (RBG), (b) hemoglobin A1c (HbA1c), (c, d) blood pressure (BP) and (e) body mass index (BMI) in diabetic patients with baseline and follow-up values and not lost to follow-up. For BMI, only patients with elevated baseline BMI (≥23.0) were included in the analysis. For systolic BP (SBP), only patients with elevated baseline SBP (>130 mm Hg) were included in the analysis. For disastolic BP (DBP), only patients with elevated baseline DBP (>80 mm Hg) were included in the analysis.

Back to article page